Free Trial
OTCMKTS:CUBT

Curative Biotechnology (CUBT) Stock Price, News & Analysis

Curative Biotechnology logo
$0.01 0.00 (-0.71%)
As of 05/29/2025 02:19 PM Eastern

About Curative Biotechnology Stock (OTCMKTS:CUBT)

Key Stats

Today's Range
$0.0120
$0.0139
50-Day Range
$0.0095
$0.0155
52-Week Range
$0.00
$0.03
Volume
23,618 shs
Average Volume
164,587 shs
Market Capitalization
$13.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Curative Biotechnology, Inc., a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. The company has an agreement with Mid-Atlantic BioTherapeutics, Inc. to develop the COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is based in Boca Raton, Florida.

Receive CUBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

CUBT Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
SFRX Seafarer Exploration Corp.
See More Headlines

CUBT Stock Analysis - Frequently Asked Questions

Curative Biotechnology's stock was trading at $0.0128 at the beginning of 2025. Since then, CUBT shares have increased by 8.6% and is now trading at $0.0139.
View the best growth stocks for 2025 here
.

Shares of CUBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Curative Biotechnology investors own include Ayala Pharmaceuticals (ADXS), Curative Biotechnology (CTYX), Invesco S&P Global Water Index ETF (CGW), Surge Battery Metals (NILIF), HEXO (HEXO), Pressure BioSciences (PBIO) and TransAtlantic Capital (TACI).

Company Calendar

Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
OTCMKTS:CUBT
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$13.47 million
Optionable
Not Optionable
Beta
0.28
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (OTCMKTS:CUBT) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners